Correlation Between Mink Therapeutics and 929089AF7

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and 929089AF7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and 929089AF7 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and VOYA FINL INC, you can compare the effects of market volatilities on Mink Therapeutics and 929089AF7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of 929089AF7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and 929089AF7.

Diversification Opportunities for Mink Therapeutics and 929089AF7

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Mink and 929089AF7 is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and VOYA FINL INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VOYA FINL INC and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with 929089AF7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VOYA FINL INC has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and 929089AF7 go up and down completely randomly.

Pair Corralation between Mink Therapeutics and 929089AF7

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the 929089AF7. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.58 times less risky than 929089AF7. The stock trades about -0.09 of its potential returns per unit of risk. The VOYA FINL INC is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  8,858  in VOYA FINL INC on September 14, 2024 and sell it today you would lose (454.00) from holding VOYA FINL INC or give up 5.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy84.13%
ValuesDaily Returns

Mink Therapeutics  vs.  VOYA FINL INC

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
VOYA FINL INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VOYA FINL INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 929089AF7 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Mink Therapeutics and 929089AF7 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and 929089AF7

The main advantage of trading using opposite Mink Therapeutics and 929089AF7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, 929089AF7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 929089AF7 will offset losses from the drop in 929089AF7's long position.
The idea behind Mink Therapeutics and VOYA FINL INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges